Corrigendum to "Bortezomib-resistant multiple myeloma patient-derived xenograft is sensitive to anti-CD47 therapy" [Leuk. Res. 122 (2022) 106949]. (May 2023)

Record Type:: Journal Article
Title:: Corrigendum to "Bortezomib-resistant multiple myeloma patient-derived xenograft is sensitive to anti-CD47 therapy" [Leuk. Res. 122 (2022) 106949]. (May 2023)
Main Title:: Corrigendum to "Bortezomib-resistant multiple myeloma patient-derived xenograft is sensitive to anti-CD47 therapy" [Leuk. Res. 122 (2022) 106949]
Authors:: Yue, Yanhua
Cao, Yang
Wang, Fei
Zhang, Naidong
Qi, Ziwei
Mao, Xunyuan
Guo, Shuxin
Li, Feng
Guo, Yanting
Lin, Yan
Dong, Weimin
Huang, Yuhui
Gu, Weiying
Abstract:
Is Part Of:: Leukemia research. Volume 128(2023)
Journal:: Leukemia research
Issue:: Volume 128(2023)
Issue Display:: Volume 128, Issue 2023 (2023)
Year:: 2023
Volume:: 128
Issue:: 2023
Issue Sort Value:: 2023-0128-2023-0000
Page Start:
Page End:
Publication Date:: 2023-05
Subjects:: Leukemia -- Periodicals
Leukemia -- Periodicals
Leucémie -- Périodiques
Leukemia
Periodicals
Electronic journals
Electronic journals
616.9941905
Journal URLs:: http://www.sciencedirect.com/science/journal/01452126 ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/j.leukres.2023.107068 ↗
Languages:: English
ISSNs:: 0145-2126
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 5185.270000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 27046.xml